Analysts expect Abvc Biopharma, Inc. to report revenue of 0.00 for Q1 23, against a range of 0.00 to 0.00. The most recent reported quarter, Q3 23, came in at 15,880.00, a 95.0% miss against the 318,474.00 consensus.
| Metric | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 312,860.00 | 42,270.00 | 589,780.00 | - | - | 15,880.00 | - | - | - | - | - | - | |||||||||||
| High Estimate | 26,926.59 | 28,001.30 | 27,874.04 | 0.00 | 347,166.35 | 345,778.05 | 0.00 | 3.68 M | 3.86 M | 4.16 M | 4.08 M | 838,101.37 | |||||||||||
| Low Estimate | 22,561.17 | 23,110.18 | 23,409.78 | 0.00 | 291,149.65 | 291,169.95 | 0.00 | 3.09 M | 3.62 M | 3.48 M | 3.64 M | 741,591.61 | |||||||||||
| Consensus Estimate | 24,743.88 | 25,555.74 | 25,641.91 | 0.00 | 319,158.00 | 318,474.00 | 0.00 | 3.39 M | 3.74 M | 3.82 M | 3.86 M | 789,846.49 |
Analysts expect Abvc Biopharma, Inc. to report earnings per share of -0.48 for Q1 23, against a range of -0.50 to -0.46. The most recent reported quarter, Q3 26, came in at 0.04, a 171.9% beat against the -0.06 consensus.
| Metric | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.60 | -1.10 | -1.50 | - | - | -0.82 | - | - | - | - | - | - | -0.13 | -0.09 | -0.14 | -0.06 | -0.03 | 0.04 | |||||
| High Estimate | -1.09 | -2.00 | -1.41 | -0.46 | -0.56 | -0.34 | -0.47 | -0.74 | -1.06 | -1.25 | -1.12 | -0.61 | -0.97 | -1.52 | -1.15 | 0.75 | 0.37 | -0.06 | |||||
| Low Estimate | -1.25 | -2.28 | -1.65 | -0.50 | -0.66 | -0.40 | -0.51 | -0.84 | -1.28 | -1.41 | -1.20 | -0.75 | -1.17 | -1.64 | -1.33 | 0.63 | 0.33 | -0.06 | |||||
| Consensus Estimate | -1.17 | -2.14 | -1.53 | -0.48 | -0.61 | -0.37 | -0.49 | -0.79 | -1.17 | -1.33 | -1.16 | -0.68 | -1.07 | -1.58 | -1.24 | 0.69 | 0.35 | -0.06 |
Pull Wall Street consensus for Abvc Biopharma, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ABVC&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ABVC", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ABVC&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();